First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005 ...

Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting Provided by GlobeNewswire May ...

The Task Force of the European Academy of Neurology and the Peripheral Nerve Society published updated guidelines in 2024 on the diagnosis and treatment of Guillain-Barré syndrome (GBS), which ...

While it is not a common condition, Guillain-Barré Syndrome (GBS) is garnering increased interest from the broader medical diagnostics industry as new cases are reported worldwide each year and linked ...

Some people will not make a full recovery and are left with long-term problems such as being unable to walk without ...

Vadodara: In a remarkable medical breakthrough, a 34-week pregnant woman diagnosed with severe Guillain-Barré Syndrome (GBS) ...

Darren’s life changed overnight when he was temporarily paralysed by the rare neurological disorder Guillain-Barré syndrome ...

It's been eight years since Rob Vasquez was diagnosed with Guillain-Barré Syndrome. Turning pain into action. 24/7 Live Fresno County North Valley South Valley Foothills/Sierra ...

Guillain-Barre syndrome (GBS) is a rare but serious autoimmune disorder in which the body's immune system mistakenly attacks the peripheral nerves, leading to muscle weakness, numbness, and, in ...

Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that ...